Clinical Trials Directory

Trials / Completed

CompletedNCT02414789

Lyme Borreliosis and Early Cutaneous Diagnostic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
84 (actual)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Test and evaluate a new diagnostic method (SRM-MS/MS: Selected Reaction Monitoring- Mass spectrometry) for Lyme Borreliosis on human skin biopsies. Patients included are those with the early skin manifestation (erythema migrans). This new proteomic method will be compared to the two existing method: culture of Borrelia and PCR detection of Borrelia (DNA detection of the bacteria).

Conditions

Interventions

TypeNameDescription
PROCEDURESkin biopsiesSkin biopsies of patients with Lyme disease (erythema migrans) infected with Borrelia burgdorferi sensu lato will be analyzed by three diagnostic techniques : molecular technique (PCR), biological technique (culture of the bacteria) and proteomics technique (SRM/ MS-MS)

Timeline

Start date
2015-08-06
Primary completion
2024-02-01
Completion
2024-02-01
First posted
2015-04-13
Last updated
2025-10-01

Locations

7 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02414789. Inclusion in this directory is not an endorsement.

Lyme Borreliosis and Early Cutaneous Diagnostic (NCT02414789) · Clinical Trials Directory